APA (7th ed.) Citation

Turan, L., Arnold-Vangsted, A., la Cour, M., Hodzic-Hadzibegovic, D., Hajari, J. N., Klefter, O. N., . . . Subhi, Y. (2025). Treatment Interval Progression and Adherence to Observe-and-Plan Regimen for Neovascular Age-Related Macular Degeneration Treated with Aflibercept 2 mg. Ophthalmology & Therapy, 14(3), 585. https://doi.org/10.1007/s40123-025-01095-1

Chicago Style (17th ed.) Citation

Turan, Leyla, Andreas Arnold-Vangsted, Morten la Cour, Delila Hodzic-Hadzibegovic, Javad N. Hajari, Oliver N. Klefter, Miklos Schneider, and Yousif Subhi. "Treatment Interval Progression and Adherence to Observe-and-Plan Regimen for Neovascular Age-Related Macular Degeneration Treated with Aflibercept 2 mg." Ophthalmology & Therapy 14, no. 3 (2025): 585. https://doi.org/10.1007/s40123-025-01095-1.

MLA (9th ed.) Citation

Turan, Leyla, et al. "Treatment Interval Progression and Adherence to Observe-and-Plan Regimen for Neovascular Age-Related Macular Degeneration Treated with Aflibercept 2 mg." Ophthalmology & Therapy, vol. 14, no. 3, 2025, p. 585, https://doi.org/10.1007/s40123-025-01095-1.